Cargando…
Fasting and weight loss: mobile application-based approach
BACKGROUND: The purpose of this study was to investigate the efficacy of intermittent fasting (IF) guidance, delivered through a smartphone application, in terms of engagement and weight loss. METHODS: We performed a retrospective chart-review study of all consecutive users with overweight or obesit...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733330/ https://www.ncbi.nlm.nih.gov/pubmed/36482492 http://dx.doi.org/10.1186/s40795-022-00645-1 |
_version_ | 1784846348883853312 |
---|---|
author | Valinskas, Sarunas Aleknavicius, Kasparas Nakrys, Marius Jonusas, Justinas |
author_facet | Valinskas, Sarunas Aleknavicius, Kasparas Nakrys, Marius Jonusas, Justinas |
author_sort | Valinskas, Sarunas |
collection | PubMed |
description | BACKGROUND: The purpose of this study was to investigate the efficacy of intermittent fasting (IF) guidance, delivered through a smartphone application, in terms of engagement and weight loss. METHODS: We performed a retrospective chart-review study of all consecutive users with overweight or obesity of the DoFasting mobile application, which integrates IF solutions for people looking to lose weight. Users with overweight and obesity at the beginning of application use, who met the inclusion criteria (entered their gender, height, and starting weight; had more than one weight entry; used the app for at least a month; had at least one active day per week with valid app-related activities) and used the application for weight loss were included in the study. RESULTS: The final study cohort comprised 22,022 consecutive users. The short-term cohort comprised 17,221 users (8585 females and 8636 males), while 4801 users (2983 females and 1818 males) were in the long-term cohort. Long-term active users of the application lost a statistically significant amount of weight over the study period and lost more than inactive users did (2.2 [3.5] vs 1.4 [3.2], p < 0.0001; the results are shown in kilograms as medians with the interquartile range in brackets). Active and long-term users were also more likely to reduce their BMI class (p < 0.05) in comparison to non-active short-term users. A multiple regression model showed that the total length of use and active days were the most significant predictors of weight loss. In-app activities such as total fasting hours, weight logging, completing challenges, and providing feedback were also statistically significant predictors of weight loss with varying contributions. CONCLUSION: We found that the DoFasting mobile application that implements IF is an effective tool for weight loss if used actively and sufficiently. TRIAL REGISTRATION: This retrospective chart review study was approved by BRANY IRB in January 2022 (study ID.: 22‐08‐034‐939). |
format | Online Article Text |
id | pubmed-9733330 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-97333302022-12-10 Fasting and weight loss: mobile application-based approach Valinskas, Sarunas Aleknavicius, Kasparas Nakrys, Marius Jonusas, Justinas BMC Nutr Research BACKGROUND: The purpose of this study was to investigate the efficacy of intermittent fasting (IF) guidance, delivered through a smartphone application, in terms of engagement and weight loss. METHODS: We performed a retrospective chart-review study of all consecutive users with overweight or obesity of the DoFasting mobile application, which integrates IF solutions for people looking to lose weight. Users with overweight and obesity at the beginning of application use, who met the inclusion criteria (entered their gender, height, and starting weight; had more than one weight entry; used the app for at least a month; had at least one active day per week with valid app-related activities) and used the application for weight loss were included in the study. RESULTS: The final study cohort comprised 22,022 consecutive users. The short-term cohort comprised 17,221 users (8585 females and 8636 males), while 4801 users (2983 females and 1818 males) were in the long-term cohort. Long-term active users of the application lost a statistically significant amount of weight over the study period and lost more than inactive users did (2.2 [3.5] vs 1.4 [3.2], p < 0.0001; the results are shown in kilograms as medians with the interquartile range in brackets). Active and long-term users were also more likely to reduce their BMI class (p < 0.05) in comparison to non-active short-term users. A multiple regression model showed that the total length of use and active days were the most significant predictors of weight loss. In-app activities such as total fasting hours, weight logging, completing challenges, and providing feedback were also statistically significant predictors of weight loss with varying contributions. CONCLUSION: We found that the DoFasting mobile application that implements IF is an effective tool for weight loss if used actively and sufficiently. TRIAL REGISTRATION: This retrospective chart review study was approved by BRANY IRB in January 2022 (study ID.: 22‐08‐034‐939). BioMed Central 2022-12-08 /pmc/articles/PMC9733330/ /pubmed/36482492 http://dx.doi.org/10.1186/s40795-022-00645-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Valinskas, Sarunas Aleknavicius, Kasparas Nakrys, Marius Jonusas, Justinas Fasting and weight loss: mobile application-based approach |
title | Fasting and weight loss: mobile application-based approach |
title_full | Fasting and weight loss: mobile application-based approach |
title_fullStr | Fasting and weight loss: mobile application-based approach |
title_full_unstemmed | Fasting and weight loss: mobile application-based approach |
title_short | Fasting and weight loss: mobile application-based approach |
title_sort | fasting and weight loss: mobile application-based approach |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733330/ https://www.ncbi.nlm.nih.gov/pubmed/36482492 http://dx.doi.org/10.1186/s40795-022-00645-1 |
work_keys_str_mv | AT valinskassarunas fastingandweightlossmobileapplicationbasedapproach AT aleknaviciuskasparas fastingandweightlossmobileapplicationbasedapproach AT nakrysmarius fastingandweightlossmobileapplicationbasedapproach AT jonusasjustinas fastingandweightlossmobileapplicationbasedapproach |